Europska Unija - hrvatski - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - infekcije respiratornih sincicijskih virusa - cjepiva - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

Europska Unija - hrvatski - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - multipli mijelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Europska Unija - hrvatski - EMA (European Medicines Agency)

janssen-cilag international nv - bedaquiline fumarate - tuberkuloza, višestruko otporna - antimikobakterija - sirturo namijenjen je za korištenje u sklopu odgovarajuće kombinacije lijekova za plućne bolesti tuberkuloze s više otporne na lijekove (МЛУ-tb) kod odraslih i adolescenata oboljelih (12 godina manje od 18 godina, a tijelo manje mase 30 kg) za učinkovito liječenje ne može biti sastavljen od razmatranja održivosti, ili prenosivost. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje antibakterijskih posrednika.

Europska Unija - hrvatski - EMA (European Medicines Agency)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - cjepiva - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

Europska Unija - hrvatski - EMA (European Medicines Agency)

ecuphar nv - enflicoxib - antiinflammatory and antirheumatic products - psi - for the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.

Europska Unija - hrvatski - EMA (European Medicines Agency)

janssen-cilag international nv - esketamine hidroklorid - depresivni poremećaj - ostali antidepresivi - spravato, u kombinaciji sa ssri ili СИОЗН je za odrasle osobe s otporan na terapiju depresivnih poremećaja, koji se nisu odazvali, barem dvije različite metode liječenja antidepresivima u ovom umjerene i teške depresivne epizode.

Europska Unija - hrvatski - EMA (European Medicines Agency)

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

cipla europe nv, de keyserlei 58-60, box-19, antwerpen, belgija - feksofenadinklorid - filmom obložena tableta - 120 mg - urbroj: jedna filmom obložena tableta sadrži 120 mg feksofenadinklorida

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

cipla europe nv, de keyserlei 58-60, box-19, antwerpen, belgija - feksofenadinklorid - filmom obložena tableta - 180 mg - urbroj: jedna filmom obložena tableta sadrži 180 mg feksofenadinklorida

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

cipla europe nv, de keyserlei 58-60, box-19, antwerpen, belgija - mometazonfuroat hidrat - sprej za nos, suspenzija - 50 mikrograma - urbroj: svaki potisak oslobađa 50 mikrograma mometazonfuroata (u obliku hidrata) kao isporučenu dozu (po potisku)